H1N1 Vaccine Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

H1N1 Vaccine Market
H1N1 Vaccine Market: By Vaccine Type (Flu Shot, FluMist), By Type of Brands (Agripal, Fiuarix , Influgen, Influvac, Nasovac, Vaxigrip) & By Geography - Forecast(2018 - 2023)
Report Code : HCR 0129
Updated Date: 24 January, 2018  

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. H1N1 Vaccine Market Overview
2. Executive Summary 
3. H1N1 Vaccine Market Landscape

   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. End-User Profiling
      3.2.2. Financial Analysis of Top 5 Players
4. H1N1 Vaccine Market Forces
   4.1. Market Drivers
   4.2. Market Constraints
   4.3. Market Challenges 
   4.4. Attractiveness of Industry 
      4.4.1. Power of Supplier
      4.4.2. Power of Consumer
      4.4.3. Threat of New Entrants
      4.4.4. Threat of Substitution
      4.4.5. Degree of Competition
5. H1N1 Vaccine Market Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis 
   5.3. Opportunity Analysis
   5.4. Product Life Cycle Analysis 
   5.5. Suppliers & Distributors
6. H1N1 Vaccine Market- By Vaccine Type
   6.1. Flu shot/ Inactivated Vaccine
   6.2. Nasal Spray/FluMist/Intranasal
7. H1N1 Vaccine Market - By Type of Brand
   7.1. Agripal
   7.2. Fiuarix
   7.3. Influgen
   7.4. Influvac
   7.5. Nasovac
   7.6. Vaxigrip
   7.7. Others
8. H1N1 Vaccine Market - By Geography
   8.1. North America
      8.1.1. The U.S.
      8.1.2. Canada
      8.1.3. Rest of North America
   8.2. Europe
      8.2.1. The U.K.
      8.2.2. Germany
      8.2.3. France
      8.2.4. Italy
      8.2.5. Rest of Europe
   8.3. Asia-Pacific
      8.3.1. China
      8.3.2. India
      8.3.3. Japan
      8.3.4. Rest of APAC
   8.4. Latin America
      8.4.1. Brazil
      8.4.2. Argentina
      8.4.3. Mexico
      8.4.4. Rest of Latin America
   8.5. Rest of the World
      8.5.1. The Middle East
      8.5.2. Africa
9. H1N1 Vaccine Market Entropy
   9.1. New Product Launches
   9.2. M&As, Collaborations, Partnerships & JVs
10. Company Profiles (Overview, Financials, Products & Services, Recent Developments, Competitors & Customers)
   10.1. Panacea Biotec Ltd.
   10.2. Glaxo Smithkline Pharmaceuticals Ltd.
   10.3. Lupin Laboratories  Ltd.
   10.4. Solvay Pharma India Pvt. Ltd.
   10.5. Serum Institute of India Ltd.
   10.6. Sanofi Pasteur
   10.7. Baxter International Inc
   10.8. Butantan Institute
   10.9. Crucell N.V.
   10.10. Green Cross Corp
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11. Appendix

   11.1. Abbreviations
   11.2. Sources
   11.3. Research Methodology
   11.4. Bibliography
   11.5. Compilation of Expert Insights
H1N1 is an influenza virus with swine origin and the disease caused by this virus is usually recognized as swine flu. This disease is contagious and can spread widely through small droplets of saliva from coughs or sneezes of infected person. This H1N1 virus was responsible for the 2009 flu pandemic. The person affected by human influenza virus suffers from general illness such as cold, fever, sore throat, muscle pains, severe headache, coughing, weakness, and general discomfort. The epidemic caused in 1918 and 1919 due to this virus caused deaths of 50 to 100 million people worldwide. This flu epidemic also occurred in 1976 and 1977-78 named as Fort Dix outbreak and Russian flu respectively which infected quite significant percentage of population. In April 2009, the U.S. and Mexico was severely affected by the outbreak of this disease. In India, nearly 31,000 people were affected and 1,900 were reported dead due to H1N1/ swine flu in 2015.

Vaccination is the only best way of treating flu caused by H1N1 influenza virus. There are two types of vaccines to treat swine flu depending on the nature of virus inserted. These include flu shot- contains inactivated virus and FluMist- contains live virus. Flu shot is inactivated vaccine containing a killed virus and injected in the arm muscle. Intramuscular vaccine or the flu shot costs less as compared to FluMist and hence caters to larger percent of population. The FluMist vaccine contains attenuated live virus and is given through nasal track. Though the FLuMist vaccine has limited customers, this is the most effective form of vaccine with fewer side effects.The rate of penetration of these vaccinations is analyzed and an in depth analysis of the same is provided in the report. There could be chances of some side effects after the injection of vaccine in the body. Some of them include- weakness, vision problem, problem in speaking, swallowing, or bladder and bowel functions, severe lower back pain, slow heart rate, trouble breathing, high fever, or unusual bruising or bleeding.

H1N1 Vaccine Market

The report highlights the major brands producing vaccines for H1N1. The major drug brands include Agripal, Fiuarix, Influgen, Influvac, Nasovac, Vaxigrip, and others. These brands are produced by the leading players in vaccine industry.  Due to the increasing deaths caused by H1N1, government of all nations including the U.S., Russia, and India have provided huge subsidies to the vaccine manufacturers. Moreover, the government is forming strong partnerships with the vaccine providers to promote the use of vaccines. These are the major factors boosting the growth of H1N1 vaccine market. However, many doctors in India and other countries are reluctant to get injected with these vaccines as they believe they are developing automatic immunity while treating swine flu patients. Besides the high cost of vaccine and lengthy and complex manufacturing process are posing great challenge to the growth of H1N1 vaccine market. The report identifies the major dynamics in H1N1 vaccine market including drivers, inhibitors, challenges and opportunities. The impact analysis of these factors is also included in the report. The report tracks and analyzes the key trends, macro factors and micro factors in the market. The entire value chain of the market along with the suppliers and distributor analysis is also included in the report.

The report provides precise and comprehensive insights on the H1N1 vaccine market in all geographies such as North America, Europe, Asia-Pacific, and Latin America. The U.S. accounts for highest share due to the high adaptive rate of the medications and disease awareness. India has high growth potential in this market due to the steps taken by Indian government towards spreading awareness and motivating the private vaccine manufacturers by forming strategic partnerships and offering good subsidies. Moreover, the countries generating high revenue globally have also been analyzed along with exhaustive coverage of developments and innovation in these countries.

The report also offers extensive research on the key players in this market and detailed insights on the competitiveness of these players. The key business strategies such as mergers & acquisitions, partnerships, collaborations, and contracts adopted by the major players are also identifies and analyzed in the report.

The major players profiled in the report include: 
  • Panacea Biotec Ltd.
  • Lupin Laboratories Ltd.
  • Baxter International Inc.
  • Crucell N.V.
  • Green Cross Corp.
List of Tables

table 1: H1N1 Vaccine Market Overview 2017-2023
table 2: H1N1 Vaccine Market Leader Analysis 2017-2018 (US$)
table 3: H1N1 Vaccine Market Product Analysis 2017-2018 (US$)
table 4: H1N1 Vaccine Market End User Analysis 2017-2018 (US$)
table 5: H1N1 Vaccine Market Patent Analysis 2013-2018* (US$)
table 6: H1N1 Vaccine Market Financial Analysis 2017-2018 (US$)
table 7: H1N1 Vaccine Market Driver Analysis 2017-2018 (US$)
table 8: H1N1 Vaccine Market Challenges Analysis 2017-2018 (US$)
table 9: H1N1 Vaccine Market Constraint Analysis 2017-2018 (US$)
table 10: H1N1 Vaccine Market Supplier Bargaining Power Analysis 2017-2018 (US$)
table 11: H1N1 Vaccine Market Buyer Bargaining Power Analysis 2017-2018 (US$)
table 12: H1N1 Vaccine Market Threat of Substitutes Analysis 2017-2018 (US$)
table 13: H1N1 Vaccine Market Threat of New Entrants Analysis 2017-2018 (US$)
table 14: H1N1 Vaccine Market Degree of Competition Analysis 2017-2018 (US$)
table 15: H1N1 Vaccine Market Value Chain Analysis 2017-2018 (US$)
table 16: H1N1 Vaccine Market Pricing Analysis 2018-2023 (US$)
table 17: H1N1 Vaccine Market Opportunities Analysis 2018-2023 (US$)
table 18: H1N1 Vaccine Market Product Life Cycle Analysis 2018-2023 (US$)
table 19: H1N1 Vaccine Market Supplier Analysis 2017-2018 (US$)
table 20: H1N1 Vaccine Market Distributor Analysis 2017-2018 (US$)
table 21: H1N1 Vaccine Market Trend Analysis 2017-2018 (US$)
table 22: H1N1 Vaccine Market Size 2017 (US$)
table 23: H1N1 Vaccine Market Forecast Analysis 2018-2023 (US$)
table 24: H1N1 Vaccine Market Sales Forecast Analysis 2018-2023 (Units)
table 25: H1N1 Vaccine Market, Revenue & Volume, By Type, 2018-2023 ($)
table 26: H1N1 Vaccine Market By Type, Revenue & Volume, By Flu shot/ Inactivated Vaccine, 2018-2023 ($)
table 27: H1N1 Vaccine Market By Type, Revenue & Volume, By Nasal Spray/FluMist/Intranasal, 2018-2023 ($)
table 28: H1N1 Vaccine Market, Revenue & Volume, By Type of Brand, 2018-2023 ($)
table 29: H1N1 Vaccine Market By Type of Brand, Revenue & Volume, By Agripal, 2018-2023 ($)
table 30: H1N1 Vaccine Market By Type of Brand, Revenue & Volume, By Fiuarix, 2018-2023 ($)
table 31: H1N1 Vaccine Market By Type of Brand, Revenue & Volume, By Influgen, 2018-2023 ($)
table 32: H1N1 Vaccine Market By Type of Brand, Revenue & Volume, By Influvac, 2018-2023 ($)
table 33: H1N1 Vaccine Market By Type of Brand, Revenue & Volume, By Nasovac, 2018-2023 ($)
table 34: North America H1N1 Vaccine Market, Revenue & Volume, By Type, 2018-2023 ($)
table 35: North America H1N1 Vaccine Market, Revenue & Volume, By Type of Brand, 2018-2023 ($)
table 36: South america H1N1 Vaccine Market, Revenue & Volume, By Type, 2018-2023 ($)
table 37: South america H1N1 Vaccine Market, Revenue & Volume, By Type of Brand, 2018-2023 ($)
table 38: Europe H1N1 Vaccine Market, Revenue & Volume, By Type, 2018-2023 ($)
table 39: Europe H1N1 Vaccine Market, Revenue & Volume, By Type of Brand, 2018-2023 ($)
table 40: APAC H1N1 Vaccine Market, Revenue & Volume, By Type, 2018-2023 ($)
table 41: APAC H1N1 Vaccine Market, Revenue & Volume, By Type of Brand, 2018-2023 ($)
table 42: Middle East & Africa H1N1 Vaccine Market, Revenue & Volume, By Type, 2018-2023 ($)
table 43: Middle East & Africa H1N1 Vaccine Market, Revenue & Volume, By Type of Brand, 2018-2023 ($)
table 44: Russia H1N1 Vaccine Market, Revenue & Volume, By Type, 2018-2023 ($)
table 45: Russia H1N1 Vaccine Market, Revenue & Volume, By Type of Brand, 2018-2023 ($)
table 46: Israel H1N1 Vaccine Market, Revenue & Volume, By Type, 2018-2023 ($)
table 47: Israel H1N1 Vaccine Market, Revenue & Volume, By Type of Brand, 2018-2023 ($)
table 48: Top Companies 2017 (US$)H1N1 Vaccine Market, Revenue & Volume
table 49: Product Launch 2017-2018H1N1 Vaccine Market, Revenue & Volume
table 50: Mergers & Acquistions 2017-2018H1N1 Vaccine Market, Revenue & Volume


List of Figures

Figure 1: Overview of H1N1 Vaccine Market 2017-2023
Figure 2: Market Share Analysis for H1N1 Vaccine Market 2017 (US$)
Figure 3: Product Comparison in H1N1 Vaccine Market 2017-2018 (US$)
Figure 4: End User Profile for H1N1 Vaccine Market 2017-2018 (US$)
Figure 5: Patent Application and Grant in H1N1 Vaccine Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in H1N1 Vaccine Market 2017-2018 (US$)
Figure 7: Market Entry Strategy in H1N1 Vaccine Market 2017-2018
Figure 8: Ecosystem Analysis in H1N1 Vaccine Market 2017
Figure 9: Average Selling Price in H1N1 Vaccine Market 2017-2023
Figure 10: Top Opportunites in H1N1 Vaccine Market 2017-2018
Figure 11: Market Life Cycle Analysis in H1N1 Vaccine Market Market Life Cycle Analysis in 3D Printing
Figure 12: GlobalBy TypeH1N1 Vaccine Market Revenue, 2018-2023 ($)
Figure 13: GlobalBy Type of Brand H1N1 Vaccine Market Revenue, 2018-2023 ($)
Figure 14: Global H1N1 Vaccine Market - By Geography
Figure 15: Global H1N1 Vaccine Market Value & Volume, By Geography, 2018-2023 ($) 
Figure 16: Global H1N1 Vaccine Market CAGR, By Geography, 2018-2023 (%)
Figure 17: North America H1N1 Vaccine Market Value & Volume, 2018-2023 ($)
Figure 18: US H1N1 Vaccine Market Value & Volume, 2018-2023 ($)
Figure 19: US GDP and Population, 2017-2018 ($)
Figure 20: US GDP – Composition of 2017, By Sector of Origin
Figure 21: US Export and Import Value & Volume, 2017-2018 ($)
Figure 22: Canada H1N1 Vaccine Market Value & Volume, 2018-2023 ($)
Figure 23: Canada GDP and Population, 2017-2018 ($)
Figure 24: Canada GDP – Composition of 2017, By Sector of Origin
Figure 25: Canada Export and Import Value & Volume, 2017-2018 ($)
Figure 26: Mexico H1N1 Vaccine Market Value & Volume, 2018-2023 ($)
Figure 27: Mexico GDP and Population, 2017-2018 ($)
Figure 28: Mexico GDP – Composition of 2017, By Sector of Origin
Figure 29: Mexico Export and Import Value & Volume, 2017-2018 ($)
Figure 30: South America H1N1 Vaccine Market South America 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 31: Brazil H1N1 Vaccine Market Value & Volume, 2018-2023 ($)
Figure 32: Brazil GDP and Population, 2017-2018 ($)
Figure 33: Brazil GDP – Composition of 2017, By Sector of Origin
Figure 34: Brazil Export and Import Value & Volume, 2017-2018 ($)
Figure 35: Venezuela H1N1 Vaccine Market Value & Volume, 2018-2023 ($)
Figure 36: Venezuela GDP and Population, 2017-2018 ($)
Figure 37: Venezuela GDP – Composition of 2017, By Sector of Origin
Figure 38: Venezuela Export and Import Value & Volume, 2017-2018 ($)
Figure 39: Argentina H1N1 Vaccine Market Value & Volume, 2018-2023 ($)
Figure 40: Argentina GDP and Population, 2017-2018 ($)
Figure 41: Argentina GDP – Composition of 2017, By Sector of Origin
Figure 42: Argentina Export and Import Value & Volume, 2017-2018 ($)
Figure 43: Ecuador H1N1 Vaccine Market Value & Volume, 2018-2023 ($)
Figure 44: Ecuador GDP and Population, 2017-2018 ($)
Figure 45: Ecuador GDP – Composition of 2017, By Sector of Origin
Figure 46: Ecuador Export and Import Value & Volume, 2017-2018 ($)
Figure 47: Peru H1N1 Vaccine Market Value & Volume, 2018-2023 ($)
Figure 48: Peru GDP and Population, 2017-2018 ($)
Figure 49: Peru GDP – Composition of 2017, By Sector of Origin
Figure 50: Peru Export and Import Value & Volume, 2017-2018 ($)
Figure 51: Colombia H1N1 Vaccine Market Value & Volume, 2018-2023 ($)
Figure 52: Colombia GDP and Population, 2017-2018 ($)
Figure 53: Colombia GDP – Composition of 2017, By Sector of Origin
Figure 54: Colombia Export and Import Value & Volume, 2017-2018 ($)
Figure 55: Costa Rica H1N1 Vaccine Market Costa Rica 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 56: Costa Rica GDP and Population, 2017-2018 ($)
Figure 57: Costa Rica GDP – Composition of 2017, By Sector of Origin
Figure 58: Costa Rica Export and Import Value & Volume, 2017-2018 ($)
Figure 59: Europe H1N1 Vaccine Market Value & Volume, 2018-2023 ($)
Figure 60: U.K H1N1 Vaccine Market Value & Volume, 2018-2023 ($)
Figure 61: U.K GDP and Population, 2017-2018 ($)
Figure 62: U.K GDP – Composition of 2017, By Sector of Origin
Figure 63: U.K Export and Import Value & Volume, 2017-2018 ($)
Figure 64: Germany H1N1 Vaccine Market Value & Volume, 2018-2023 ($)
Figure 65: Germany GDP and Population, 2017-2018 ($)
Figure 66: Germany GDP – Composition of 2017, By Sector of Origin
Figure 67: Germany Export and Import Value & Volume, 2017-2018 ($)
Figure 68: Italy H1N1 Vaccine Market Value & Volume, 2018-2023 ($)
Figure 69: Italy GDP and Population, 2017-2018 ($)
Figure 70: Italy GDP – Composition of 2017, By Sector of Origin
Figure 71: Italy Export and Import Value & Volume, 2017-2018 ($)
Figure 72: France H1N1 Vaccine Market Value & Volume, 2018-2023 ($)
Figure 73: France GDP and Population, 2017-2018 ($)
Figure 74: France GDP – Composition of 2017, By Sector of Origin
Figure 75: France Export and Import Value & Volume, 2017-2018 ($)
Figure 76: Netherlands H1N1 Vaccine Market Value & Volume, 2018-2023 ($)
Figure 77: Netherlands GDP and Population, 2017-2018 ($)
Figure 78: Netherlands GDP – Composition of 2017, By Sector of Origin
Figure 79: Netherlands Export and Import Value & Volume, 2017-2018 ($)
Figure 80: Belgium H1N1 Vaccine Market Value & Volume, 2018-2023 ($)
Figure 81: Belgium GDP and Population, 2017-2018 ($)
Figure 82: Belgium GDP – Composition of 2017, By Sector of Origin
Figure 83: Belgium Export and Import Value & Volume, 2017-2018 ($)
Figure 84: Spain H1N1 Vaccine Market Value & Volume, 2018-2023 ($)
Figure 85: Spain GDP and Population, 2017-2018 ($)
Figure 86: Spain GDP – Composition of 2017, By Sector of Origin
Figure 87: Spain Export and Import Value & Volume, 2017-2018 ($)
Figure 88: Denmark H1N1 Vaccine Market Value & Volume, 2018-2023 ($)
Figure 89: Denmark GDP and Population, 2017-2018 ($)
Figure 90: Denmark GDP – Composition of 2017, By Sector of Origin
Figure 91: Denmark Export and Import Value & Volume, 2017-2018 ($)
Figure 92: APAC H1N1 Vaccine Market Value & Volume, 2018-2023 ($)
Figure 93: China H1N1 Vaccine Market Value & Volume, 2018-2023
Figure 94: China GDP and Population, 2017-2018 ($)
Figure 95: China GDP – Composition of 2017, By Sector of Origin
Figure 96: China Export and Import Value & Volume, 2017-2018 ($)H1N1 Vaccine Market China Export and Import Value & Volume, 2017-2018 ($)
Figure 97: Australia H1N1 Vaccine Market Value & Volume, 2018-2023 ($)
Figure 98: Australia GDP and Population, 2017-2018 ($)
Figure 99: Australia GDP – Composition of 2017, By Sector of Origin
Figure 100: Australia Export and Import Value & Volume, 2017-2018 ($)
Figure 101: South Korea H1N1 Vaccine Market Value & Volume, 2018-2023 ($)
Figure 102: South Korea GDP and Population, 2017-2018 ($)
Figure 103: South Korea GDP – Composition of 2017, By Sector of Origin
Figure 104: South Korea Export and Import Value & Volume, 2017-2018 ($)
Figure 105: India H1N1 Vaccine Market Value & Volume, 2018-2023 ($)
Figure 106: India GDP and Population, 2017-2018 ($)
Figure 107: India GDP – Composition of 2017, By Sector of Origin
Figure 108: India Export and Import Value & Volume, 2017-2018 ($)
Figure 109: Taiwan H1N1 Vaccine Market Taiwan 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 110: Taiwan GDP and Population, 2017-2018 ($)
Figure 111: Taiwan GDP – Composition of 2017, By Sector of Origin
Figure 112: Taiwan Export and Import Value & Volume, 2017-2018 ($)
Figure 113: Malaysia H1N1 Vaccine Market Malaysia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 114: Malaysia GDP and Population, 2017-2018 ($)
Figure 115: Malaysia GDP – Composition of 2017, By Sector of Origin
Figure 116: Malaysia Export and Import Value & Volume, 2017-2018 ($)
Figure 117: Hong Kong H1N1 Vaccine Market Hong Kong 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 118: Hong Kong GDP and Population, 2017-2018 ($)
Figure 119: Hong Kong GDP – Composition of 2017, By Sector of Origin
Figure 120: Hong Kong Export and Import Value & Volume, 2017-2018 ($)
Figure 121: Middle East & Africa H1N1 Vaccine Market Middle East & Africa 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 122: Russia H1N1 Vaccine Market Russia 3D Printing Market Value & Volume, 2018-2023 ($)
Figure 123: Russia GDP and Population, 2017-2018 ($)
Figure 124: Russia GDP – Composition of 2017, By Sector of Origin
Figure 125: Russia Export and Import Value & Volume, 2017-2018 ($)
Figure 126: Israel H1N1 Vaccine Market Value & Volume, 2018-2023 ($)
Figure 127: Israel GDP and Population, 2017-2018 ($)
Figure 128: Israel GDP – Composition of 2017, By Sector of Origin
Figure 129: Israel Export and Import Value & Volume, 2017-2018 ($)
Figure 130: Entropy Share, By Strategies, 2017-2018* (%)H1N1 Vaccine Market
Figure 131: Developments, 2017-2018*H1N1 Vaccine Market
Figure 132: Company 1 H1N1 Vaccine Market Net Revenue, By Years, 2017-2018* ($)
Figure 133: Company 1 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2017 (%)
Figure 134: Company 1 H1N1 Vaccine Market Net Sales Share, By Geography, 2017 (%)
Figure 135: Company 2 H1N1 Vaccine Market Net Revenue, By Years, 2017-2018* ($)
Figure 136: Company 2 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2017 (%)
Figure 137: Company 2 H1N1 Vaccine Market Net Sales Share, By Geography, 2017 (%)
Figure 138: Company 3 H1N1 Vaccine Market Net Revenue, By Years, 2017-2018* ($)
Figure 139: Company 3 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2017 (%)
Figure 140: Company 3 H1N1 Vaccine Market Net Sales Share, By Geography, 2017 (%)
Figure 141: Company 4 H1N1 Vaccine Market Net Revenue, By Years, 2017-2018* ($)
Figure 142: Company 4 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2017 (%)
Figure 143: Company 4 H1N1 Vaccine Market Net Sales Share, By Geography, 2017 (%)
Figure 144: Company 5 H1N1 Vaccine Market Net Revenue, By Years, 2017-2018* ($)
Figure 145: Company 5 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2017 (%)
Figure 146: Company 5 H1N1 Vaccine Market Net Sales Share, By Geography, 2017 (%)
Figure 147: Company 6 H1N1 Vaccine Market Net Revenue, By Years, 2017-2018* ($)
Figure 148: Company 6 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2017 (%)
Figure 149: Company 6 H1N1 Vaccine Market Net Sales Share, By Geography, 2017 (%)
Figure 150: Company 7 H1N1 Vaccine Market Net Revenue, By Years, 2017-2018* ($)
Figure 151: Company 7 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2017 (%)
Figure 152: Company 7 H1N1 Vaccine Market Net Sales Share, By Geography, 2017 (%)
Figure 153: Company 8 H1N1 Vaccine Market Net Revenue, By Years, 2017-2018* ($)
Figure 154: Company 8 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2017 (%)
Figure 155: Company 8 H1N1 Vaccine Market Net Sales Share, By Geography, 2017 (%)
Figure 156: Company 9 H1N1 Vaccine Market Net Revenue, By Years, 2017-2018* ($)
Figure 157: Company 9 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2017 (%)
Figure 158: Company 9 H1N1 Vaccine Market Net Sales Share, By Geography, 2017 (%)
Figure 159: Company 10 H1N1 Vaccine Market Net Revenue, By Years, 2017-2018* ($)
Figure 160: Company 10 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2017 (%)
Figure 161: Company 10 H1N1 Vaccine Market Net Sales Share, By Geography, 2017 (%)
Figure 162: Company 11 H1N1 Vaccine Market Net Revenue, By Years, 2017-2018* ($)
Figure 163: Company 11 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2017 (%)
Figure 164: Company 11 H1N1 Vaccine Market Net Sales Share, By Geography, 2017 (%)
Figure 165: Company 12 H1N1 Vaccine Market Net Revenue, By Years, 2017-2018* ($)
Figure 166: Company 12 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2017 (%)
Figure 167: Company 12 H1N1 Vaccine Market Net Sales Share, By Geography, 2017 (%)
Figure 168: Company 13 H1N1 Vaccine Market Net Revenue, By Years, 2017-2018* ($)
Figure 169: Company 13 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2017 (%)
Figure 170: Company 13 H1N1 Vaccine Market Net Sales Share, By Geography, 2017 (%)
Figure 171: Company 14 H1N1 Vaccine Market Net Revenue, By Years, 2017-2018* ($)
Figure 172: Company 14 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2017 (%)
Figure 173: Company 14 H1N1 Vaccine Market Net Sales Share, By Geography, 2017 (%)
Figure 174: Company 15 H1N1 Vaccine Market Net Revenue, By Years, 2017-2018* ($)
Figure 175: Company 15 H1N1 Vaccine Market Net Revenue Share, By Business segments, 2017 (%)
Figure 176: Company 15 H1N1 Vaccine Market Net Sales Share, By Geography, 2017 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll